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Abstract
Background: Adenosine stress cardiovascular magnetic resonance (CMR) has been proven an effective tool in detection
of reversible ischemia. Limited evidence is available regarding its accuracy in the setting of acute coronary syndromes,
particularly in evaluating the significance of non-culprit vessel ischaemia. Adenosine stress CMR and recent advances in
semi-quantitative image analysis may prove effective in this area. We sought to determine the diagnostic accuracy of
semi-quantitative versus visual assessment of adenosine stress CMR in detecting ischemia in non-culprit territory vessels
early after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).
Methods: Patients were prospectively enrolled in a CMR imaging protocol with rest and adenosine stress
perfusion, viability and cardiac functional assessment 3 days after successful primary-PCI for STEMI. Three short axis
slices each divided into 6 segments on first pass adenosine perfusion were visually and semi-quantitatively
analysed. Diagnostic accuracy of both methods was compared with non-culprit territory vessels utilising
quantitative coronary angiography (QCA) with significant stenosis defined as ≥70%.
Results: Fifty patients (age 59 ± 12 years) admitted with STEMI were evaluated. All subjects tolerated the
adenosine stress CMR imaging protocol with no significant complications. The cohort consisted of 41% anterior
and 59% non anterior infarctions. There were a total of 100 non-culprit territory vessels, identified on QCA. The
diagnostic accuracy of semi-quantitative analysis was 96% with sensitivity of 99%, specificity of 67%, positive
predictive value (PPV) of 97% and negative predictive value (NPV) of 86%. Visual analysis had a diagnostic accuracy
of 93% with sensitivity of 96%, specificity of 50%, PPV of 97% and NPV of 43%.
Conclusion: Adenosine stress CMR allows accurate detection of non-culprit territory stenosis in patients successfully
treated with primary-PCI post STEMI. Semi-quantitative analysis may be required for improved accuracy. Larger
studies are however required to demonstrate that early detection of non-culprit vessel ischemia in the post STEMI
setting provides a meaningful test to guide clinical decision making and ultimately improved patient outcomes.
Background
Vasodilator induced myocardial perfusion defects are
widely used in both nuclear and magnetic resonance
based non-invasive imaging studies to detect myocardial
ischemia. It offers functional relevance not provided by
angiographic assessment. Clinical routine measurements
of myocardial perfusion can be performed effectively
with single-photon emission computer tomography
(SPECT) and positron emission tomography (PET) stu-
dies. Cardiovascular magnetic resonance (CMR) however
provides superior spatial resolution with the ability to
detect subendocardial defects [1-3] as well as additional
benefits regarding the evaluation of valvular disease and
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any medium, provided the original work is properly cited.excellent assessment of left ventricular structure, func-
tion and viability.
It is now well established that up to 20-30% of patients
following an admission for an acute coronary syndrome
will have a further cardiovascular event [4-6]. It has been
recently shown that half of these events will be at a non-
culprit site [4]. This is particularly an issue in the ST-
segment elevation myocardial infarction (STEMI) setting
where up to 40% ‘significant’ non-culprit angiographic dis-
ease is seen at primary percutaneous coronary intervention
(PCI). While it is well established that intervening on a
non-culprit lesion at the time of primary-PCI is associated
with adverse outcomes [7-9] identifying an early non-inva-
sive imaging modality to effectively identify non-culprit
vessel ischemia, may identify high-risk lesions.
As there is uncertainty regarding the effectiveness of
adenosine in the immediate post infarct period due to
potential microvascular dysfunction in the infarcted ter-
ritory, the focus of our study was to compare the effec-
tiveness of semi- quantitative versus visual evaluation of
adenosine stress CMR in detecting non-culprit ischemia
in the post primary-PCI setting, compared to quantita-
tive coronary angiography (QCA).
Methods
Study population
All subjects gave written informed consent in accordance
with local human research and ethics committee approval.
We prospectively studied patients with acute STEMI who
underwent primary PCI, between April 2008 and April
2009. We defined STEMI as chest pain for at least 30 min-
utes and an ECG demonstrating ST-segment elevation of
> 0.1 mV in ≥2 contiguous leads. Patients aged < 18 years,
previous myocardial infarction in the same territory, atrio-
ventricular block of grade II or higher, severe asthma of
chronic obstructive airways disease, contraindications to
CMR, (eg, pacemaker implantation or claustrophobia)
contraindication to gadopentetate dimeglumine.(eg,
known hypersensitivity to gadopentetate dimeglumine or
creatinine clearance ≤60 ml/min/1.73 m
2) or pregnancy
were excluded from the study. All patients were advised
not to drink tea or coffee within 24 hours before the
examinations. All participants gave written consent to the
study protocol. The adenosine stress CMR was performed
on day 3 following primary PCI with non-culprit terri-
tories defined by quantitative coronary angiography data
acquired at the initial primary PCI.
Adenosine infusion protocol
Adenosine (Adenoscan
®, Sanofi-Synthelabo) was infused
at 140 μg/kg/min through an antecubital vein using an
accurate syringe pump (Graseby
® 3500). The target time
of the infusion was 3 minutes, however if patients
developed persistent or symptomatic 3
rd AV block, severe
hypotension (systolic blood pressure < 90 mmHg) or
bronchospasm, infusion was discontinued. The attending
physicians had aminophylline for adenosine receptor
antagonism, nitroglycerine for persistent chest pain, atro-
pine for persistent AV block and a fully equipped crash
trolley with defibrillator if required.
CMR
All CMR studies were performed using a 1.5 T MRI scan-
ner (Magnetom Avanto, Siemens, Germany) equipped
with a dedicated cardiac software package and a cardiac
phased array surface coil. During the last minute of adeno-
sine infusion a gadolinium-based contrast agent (Dimeglu-
mine gadopentetate, Magnevist, Bayer) was administered
intravenously at 0.1 mmol/kg body weight (injection rate,
7 ml/s), followed by at least 30 mL saline flush at the same
rate [10,11]. Perfusion imaging (echo time 1.08 ms, repeti-
tion time 2.2 ms, saturation recovery time 100 ms, shot
time 100 ms, voxel size 2.5 × 1.9 × 10 mm; flip angle 10°)
was performed every cardiac cycle during the first pass,
using a T1-weighted fast low-angle single shot gradient-
echo sequence (GRE). Parallel acquisition method using
generalised autocalibrating partially parallel acquisition
(GRAPPA) was utilised [12]. Three short axis slices, posi-
tioned from base to the apex of the left ventricle, were
obtained. The same imaging sequence was repeated 20
minutes later without adenosine to obtain perfusion
images at rest.
CMR Analysis
Left ventricular function and late gadolinium enhancement
analysis
Left ventricular ejection fraction (LVEF), volume and
mass were measured upon cine images using commer-
cially available software (M A S S ,M e d i s ,T h eN e t h e r -
lands). Papillary muscles and pericardial fat were
excluded from calculations. In brief, the end-diastolic
and end-systolic cine frames were identified for each slice
and the endocardial and epicardial borders were manu-
ally traced. The end-diastolic and end-systolic volumes
were then calculated using Simpson’s true disk summa-
tion technique (i.e. sum of cavity sizes across all continu-
ous slices), as previously described [13]. Late gadolinium
enhancement (LGE) images were assessed both for scar
mass and microvascular obstruction (MVO). Scar mass
was semi-quantitatively quantified using the full width at
half maximum technique (MAS S ,M e d i s ,T h eN e t h e r -
lands) while MVO was manually planimetered [14].
Microvascular obstruction on LGE imaging was defined
as late hypo-enhancement within a hyper-enhanced
region [15,16]. Microvascular obstruction was included
in the calculation of the total scar mass.
Wong et al. Journal of Cardiovascular Magnetic Resonance 2011, 13:62
http://www.jcmr-online.com/content/13/1/62
Page 2 of 8Visual Analysis
Visual analysis of the CMR perfusion was done off-line
by consensus of two experienced observers by an exami-
ner blinded to coronary angiography findings. Rest and
stress perfusion and the late gadolinium enhancement
images of three short axis sections (base, mid and apex)
were viewed side by side. If the signal intensity on stress
perfusion appeared lower in an area of myocardium for
at least three dynamic images compared with remote
myocardium, it was considered to be ischemic, as pre-
vious described [17]. If the same signal intensity
abnormality was seen in the rest and stress perfusion
images and there was no evidence of scar on late con-
trast enhanced images, the defect was considered an
artefact [17]. (Figure 1 & 2)
Semi-quantitative analysis
The endocardial and epicardial contours of three short
axis sections (base, mid and apex) were traced (QMASS,
Version 7.2, Medical Imaging Solutions, Leiden, the
Netherlands) and corrected manually for displacements
(eg. breathing) by an examiner blinded to coronary
angiography findings.
All three short axis sections were divided into six
equiangular segments starting in a clockwise direction
from the anterior septal insertion of the right ventricle
(Figure 3) [18]. Segments were assigned to vascular
regions according to the segmental model of the Ameri-
can Society of Echocardiography, with modifications to
correct for variable coronary dominances as previously
described [19]. Segments 6, 1 and 2 were assigned to
the left anterior descending artery; segments 2, 3 and 4
were assigned to the circumflex artery; and segments 4
and 5 were assigned to the right coronary artery.
Within each segment, signal intensity was measured
by defining regions of interest that excluded the inner
10% and outer 30% of the myocardium to get stronger
weighting of the subendocardium and reduce influences
from the LV as previously described [3] using commer-
cially available software (QMASS Version 7.2, Medis,
Netherlands).
The subendocardial signal intensity-time curves were
generated for all segments by obtaining signal intensity
on consecutive images before and during arrival of con-
trast material. The signal intensity-time curve for the left
ventricle was generated on the basal section as a measure
of input function. (Figure 1 & 2)The maximal initial
upslope of every signal intensity-time curve was deter-
mined by using a sliding window with a four- point linear
fit for the myocardium and a three-point fit for the left
ventricle as previously described [19]. Myocardial
Figure 1 Example of perfusion measurement in a patient with MPRI of 0.6 in the left anterior descending artery which has 81%
stenosis on QCA. A) Perfusion defect (yellow arrow) in anteroseptal wall on left ventricular short axis. Perfusion defect (white arrow) in inferior
wall most likely secondary to microvascular obstruction within infarct B) No perfusion defect at rest in anteroseptal wall of left ventricle.
Perfusion defect (white arrow) in inferior wall within infarct most likely secondary to microvascular obstruction C) Signal intensity-time curve in
anteroseptal wall at stress. Red line represents signal intensity-time curve for left ventricle while blue line represents signal intensity-time curve
for anteroseptum segment D) Signal intensity-time curve in anteroseptal wall at rest. Red line represents signal intensity-time curve for left
ventricle while blue line represents signal intensity-time curve for anteroseptum segment.
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correct them for the timing and dispersion of the bolus
contrast material.
For each segment, the MPRI was calculated by divid-
ing the value at stress over rest. MPRI of a vascular
r e g i o nw a sd e t e r m i n e db ya n a l y s i so fo n l yt h es e c o n d
smallest value of MPRI in the vascular region with the
use of a cutoff of 1.1 [3].
Quantitative Coronary Angiography
The quantitative coronary analyses of the non-culprit
stenotic lesions were performed on a dedicated soft-
ware tool (QCA-CMS 6.0, Medis, Netherlands).
Orthogonal views of coronary angiograms were
obtained during primary-PCI for analysis. Intracoron-
ary gliceryl trinitrate (GTN) was routinely used prior
to assessment of non-culprit vessel angiographic analy-
sis. The quantitative measurements were performed on
end-diastolic frames of the angiograms by an investiga-
t o rw h ow a sb l i n d e dt ot h er e s u l t so ft h ea d e n o s i n e
stress CMR results. The reference diameter, lesion
length and minimal luminal diameter were measured
and the reference diameter was determined by software
at the interpolation line between the normal segments
proximal and distal to the stenosis [20,21]. The dia-
meter stenosis (DS) was calculated as percent stenosis
Figure 2 Example of myocardial perfusion measurement in a patient with MPRI of 1.96 in the left anterior descending artery which
has 43% stenosis on QCA. A) No evidence of perfusion defect in the left anterior descending artery territory at stress B) No evidence of
perfusion defect in the left anterior descending artery territory at rest C) Signal intensity-time curve of anteroseptal wall of left ventricle at stress
D) Signal intensity-time curve of anteroseptal wall of left ventricle at rest.
Figure 3 Diagrams show segments assigned to vascular regions. On every section, segments 6, 1, and 2 were assigned to the left anterior
descending artery (LAD); segments 2, 3, and 4, to the circumflex artery (LCX); and segments 4 and 5, to the right coronary artery (RCA).
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stenosis as ≥70%.
Statistical Analysis
Continuous variables were expressed as means ± standard
deviations. The diagnostic accuracy in terms of sensitivity,
specificity and positive and negative predictive values of
CMR for detecting a significant coronary stenosis (≥70%)
on QCA was determined. Comparisons between ordinal
variables were made using Chi square analysis. A probabil-
ity (p) value < 0.05 was considered significant. Receiver
operating characteristic (ROC) analyses was performed to
evaluate the diagnostic potential of MPRI derived by semi-
quantitative analysis in detecting non-culprit territory ste-
nosis. Area under the curve (AUC) was determined.
Results
A total of 61 patients were recruited to undergo con-
trast enhanced CMR 3 ± 2 days post STEMI. Five
patients had history of asthma, three patients were
claustrophobic and unable to complete the CMR study
and three patients had poor quality images due to rapid
atrial fibrillation. A total of 50 patients successfully
underwent adenosine stress CMR. Baseline demo-
graphics are shown in Table 1. One hundred non-culprit
vessels were identified by QCA, 31 left anterior descend-
ing artery, 43 left circumflex artery and 26 right coron-
a r ya r t e r yl e s i o n s .T h e r ew e r e7( 1 4 % )p a t i e n t sw i t h
non- culprit territory stenosis. Mean left ventricular
ejection fraction of patients was 57 ± 11% (mean ± SD).
All 50 patients completed the adenosine stress CMR
study, which was undertaken at a mean of 3 ± 2 days
post primary PCI. During adenosine stress CMR perfu-
sion, most patients reported at least one mild symptoms
of flushing, breathlessness or chest discomfort. No
patients developed significant AV block or hypotension.
The heart rate and rate-pressure product obtained at
stress were significantly higher than those obtained at
rest. (Table 2)
Mean minimal luminal diameter of the stenotic lesions
was 0.9 ± 0.6 mm with a mean reference diameter of 3.3 ±
0.9 mm, yielding a mean diameter stenosis of 79 ± 4.4%.
Mean length of the stenotic lesions was 16.5 ± 5.3 mm.
The MPRI in coronary arteries with diameter stenosis <
70% was higher (2.18 ± 0.72, mean ± SD) than MPRI in
coronary arteries with diameter stenosis ≥70% (0.98 ±
0.48, mean ± SD).
Visual assessment of the adenosine stress CMR study
compared to ‘gold standard’ QCA showed 96% sensitiv-
ity, 50% specificity, 97% positive predictive value, 43%
negative predictive value and diagnostic odds ratio of
22.5. The semi-quantitative assessment of the adenosine
stress CMR study utilising a MPRI cut- off of 1.1 com-
pared to ‘gold standard’ QCA showed 99% sensitivity,
67% specificity, 97% positive predictive value, 86% nega-
tive predictive value and diagnostic odds ratio of 180.
O nR O Ca n a l y s i s ,t h ea r e au n d e rt h ec u r v e( A U C )o f
MPRI in detecting non-culprit territory stenosis ≥70%
was 0.94 (Figure 4). A retrospectively determined cut-off
value that maximised the sensitivity and specificity of
MPRI in our study was also determined. Utilising a
MPRI cut-off of 1.15, the sensitivity was 86%, 95% speci-
ficity, 55% positive predictive value and 99% negative
predictive value and diagnostic odds ratio of 107.
Semi-quantitative analysis reproducibility
Semi-quantitative analysis showed good reproducibility
between observers in 10 randomly selected patients. The
intraclass coefficient was 0.84 (p < 0.001).
Table 1 Patient demographics
Demographic
Age, mean ± SD 59 ± 12
Male: Female 43: 7
Risk factor, n (%)
Current smoker 16 (32)
Diabetes mellitus 8 (16)
Hypertension 20 (40)
Hypercholesterolemia 16 (32)
Previous MI 4 (8)
Family history of IHD 12 (24)
Stroke 3 (6)
Peripheral vascular disease 4 (8)






Infarct location, n (%)
Anterior 21 (41)
Non-anterior 29 (59)
Table 2 Summary of Hemodynamic Data
Parameter Adenosine CMR Imaging
Measurements
Heart rate (beats/min)
Rest 64 ± 9
Stress 78 ± 12
Systolic blood pressure (mm
Hg)
Rest 137 ± 25
Stress 140 ± 24
Rate-pressure product
Rest 8809 ± 2334
Stress 11008 ± 2873
Data are means ± standard deviations.
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Our study shows that semi-quantitative assessment of
adenosine stress CMR has good diagnostic accuracy in
detecting non-culprit artery stenosis early after primary-
PCI for STEMI, with a twofold improvement in negative
predictive value compared to visual assessment.
Assessment of non-culprit artery stenosis after primary-
PCI is essential as up to 40% of patients presenting with
STEMI have multivessel disease [22]. The current clinical
recommendation is that a deferred angioplasty strategy of
non-culprit lesions should remain the standard interven-
tional approach in patients with STEMI undergoing pri-
mary-PCI. It is accepted that intervening on non-culprit
vessels at the time of primary-PCI is associated with
adverse outcomes [8,9]. A recent meta-analysis that
included 18 studies and more than 40 000 patients showed
that multivessel PCI was associated with the highest rates
of death in short and long-term follow up when compared
with culprit-lesion PCI and staged PCI [7].
However it has been recently shown that half of all
cardiovascular events that occur following an acute cor-
onary syndrome occur at a non-culprit lesion [4]. While
the PROSPECT study showed in 697 patients that intra-
vascular ultrasound derived independent risk factors
that would indicate a non-culprit lesion was associated
with a recurrent clinical event included plaque burden
and thin-cap fibroatheroma on radiofrequency analysis,
no assessment of ischemia was performed. As many
events following ACS occur without warning symptoms,
an early non-invasive reliable test may indicate high risk
non-culprit lesions that ultimately may be proven to be
risky to adopt a ‘symptom’ driven strategy for
revascularisation.
Myocardial perfusion assessment can be performed
visually by comparing the rest and stress scans together on
a viewing platform. This allows recognition of perfusion
defects and discrimination from artefacts [23]. The sensi-
tivity utilising the visual analysis method ranged from 81
to 91% in previous studies while specificity ranged from 62
to 85% [24-26]. The sensitivity of visual analysis in our
study (97%) was comparable to previous studies. However,
our specificity of 50% was lower than previous published
studies. This could be explained by the high prevalence of
diabetes (16%), hypertension (40%) and hypercholesterole-
mia (32%) in our patients causing microcirculatory dys-
function. In addition, the presence of acutely injured
myocardium or variable amounts of scar may have an
unpredictable effect on the visual interpretation of myo-
cardial perfusion. The presence of microvascular obstruc-
tion in the infarct region could also contribute to the
difficulty in assessing for dynamic change visually in
remote myocardium. There is also no current consensus
in the definition of an artefact, most commonly dark rim
artefact, based on the persistence of a defect. The use of
an arbitrary cut off such as persistence of less than 3
phases compared to 6 phases described by other groups
for artefact may explain the low specificity. The negative
predictive value of (47%) was suboptimal with the visual
assessment methodology for evaluating ischemia.
Semi-quantitative assessment of myocardial perfusion
had also been previously studied and validated with other
techniques such as fractional flow reserve (FFR) and quan-
titative coronary angiography (QCA). However different
methodologies had yielded different cut-off values for
functional significant ischemia [3,18,19]. These studies
examined the diagnostic accuracy of semi-quantitative
assessment for detecting significant coronary artery disease
in patients referred for investigation of suspected angina.
The sensitivity of the subendocardial methodology
described by Barmeyer et al using a cutoff MPRI value of
1.21 was 84% while the specificity was 75% [18]. On the
other hand the sensitivity of the subendocardial methodol-
ogy described by Nagel et al using a cutoff MPRI value of
1.1 was 88% with a specificity of 90% [3]. Nonetheless,
these cutoff values were retrospectively determined by
ROC analysis which may lead to an optimistic accuracy of
the technique.
To our knowledge, no studies had ever examined the
diagnostic accuracy of semi-quantitative assessment of
adenosine stress CMR in patients post primary-PCI for
STEMI. Hence, no previous methodologies or cut-off
values had ever been described in this setting. We chose
the methodology previously validated by Nagel et al and
prospectively examined the diagnostic accuracy of this
method compared to QCA. In addition, our retrospec-
tively determined MPRI of 1.15 was similar to the cut-off
value of 1.1 validated by Nagel et al. This showed excellent
Figure 4 Receiver operator curve of MPRI in detection of non-
culprit territory stenosis ≥ 70%. The area under the curve for
MPRI was 0.94. Red arrow indicates the MPRI cut-off of 1.1.
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value. The small number of patients with severe non-
culprit vessel stenosis could have contributed to the diag-
nostic accuracy. Therefore further larger studies with
higher prevalence of non-culprit stenosis are required to
compare the diagnostic accuracy of semi-quantitative and
visual analysis of adenosine stress CMR post STEMI.
Limitations
A relatively small size of the patient population might
represent a limitation of the study. A larger sample size
would have allowed subgroup analysis of the influence
of infarct size and microvascular obstruction on MPRI
in non-culprit territory.
Despite the excellent results of adenosine stress CMR
for accurate detection of non- culprit territory stenosis,
there are some important limitations. Claustrophobia
remains problematic while adenosine is contraindicated
in asthmatics and patients with high degree AV block.
Patients with permanent pacemakers would also be
ineligible for this diagnostic test.
Although we performed both visual and semi-quantita-
tive analysis, the CMR protocol was optimised for visual
analysis. For semi-quantitative analysis, generating the sig-
nal intensity time curves for calculation of the upslope
from the CMR images although reproducible is time con-
suming. Manual segmentation of the myocardium and
correction for diaphragmatic motion had to be performed.
In addition, although the MPRI cut-off derived from our
study approximates the MPRI cut-off of 1.1 previously
described, generalising this cut-off across different CMR
protocols will require further studies. This therefore
reduces the use of this technique for clinical routine mea-
surements and hence majority of centers continue to use
visual analysis for the assessment of clinical myocardial
perfusion scans.
Conclusions
Adenosine stress CMR allows accurate detection of non-
culprit territory stenosis in patients successfully treated
with primary percutaneous intervention post STEMI.
Semi-quantitative analysis may be required for improved
accuracy. Larger studies are however required to
demonstrate that early detection of non-culprit vessel
ischemia in the post STEMI setting provides a meaning-
ful test to guide clinical decision making and ultimately
improved patient outcomes.
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